In most gliomas, ATRX deletion in combination with IDH mutation leads to immunosuppression, whereas IDH-mutant, ATRX-mutant astrocytomas exhibit greater immune cell infiltration than IDH-mutant, ATRX wild-type oligodendrogliomas (Venteicher et al., 2017). This evidence concerns the gene ATRX and glioma.